Form 4 filed by Torley Helen
Torley Helen filed this Form 4 on HALO (HALOZYME THERAPEUTICS, INC.) with 18 transaction rows and 0 holding rows, accepted by EDGAR 2026-10-08 23:56:19 UTC.
- Accession
- 0001159036-26-000140
- Filer
- CIK 1528185
- Filed
- 2026-10-08
- Accepted by EDGAR
- Ingested
- Source
- EDGAR live feed
Issuer and reporting owners
Issuer: HALO · HALOZYME THERAPEUTICS, INC. (CIK 1159036)
- Torley Helen director, officer (PRESIDENT AND CEO)
Rows
| Security | Date | Code | Shares | Price | Owned after | Ownership |
|---|---|---|---|---|---|---|
| Common Stock | 2026-10-06 | M exercised | +20,000 | $18.41 | 787,780 | D |
| Common Stock | 2026-10-06 | S sold | -2,300 | $107.902 | 785,480 | D |
| Common Stock | 2026-10-06 | S sold | -6,000 | $109.334 | 779,480 | D |
| Common Stock | 2026-10-06 | S sold | -9,920 | $109.891 | 769,560 | D |
| Common Stock | 2026-10-06 | S sold | -1,780 | $110.812 | 767,780 | D |
| Common Stock | 2026-10-07 | M exercised | +20,000 | $18.41 | 787,780 | D |
| Common Stock | 2026-10-07 | S sold | -8,600 | $111.031 | 779,180 | D |
| Common Stock | 2026-10-07 | S sold | -10,300 | $111.839 | 768,880 | D |
| Common Stock | 2026-10-07 | S sold | -900 | $112.78 | 767,980 | D |
| Common Stock | 2026-10-07 | S sold | -200 | $113.693 | 767,780 | D |
| Common Stock | 2026-10-08 | M exercised | +20,000 | $18.41 | 787,780 | D |
| Common Stock | 2026-10-08 | S sold | -4,810 | $108.179 | 782,970 | D |
| Common Stock | 2026-10-08 | S sold | -3,090 | $108.908 | 779,880 | D |
| Common Stock | 2026-10-08 | S sold | -11,900 | $109.995 | 767,980 | D |
| Common Stock | 2026-10-08 | S sold | -200 | $110.51 | 767,780 | D |
| Option to Purchase Common Stock derivative | 2026-10-06 | M exercised | -20,000 | $18.41 | 61,552 | D |
| Option to Purchase Common Stock derivative | 2026-10-07 | M exercised | -20,000 | $18.41 | 41,552 | D |
| Option to Purchase Common Stock derivative | 2026-10-08 | M exercised | -20,000 | $18.41 | 21,552 | D |